Arkolith/Insider Trading/EIKN/Form 4

Frazier Kenneth C

DirectorEikon Therapeutics, Inc. (EIKN) · full profile →Form 4 · filed Feb 6, 2026
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Buy(P)111K$18.00$2.0M111K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-041555) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML